A1 Refereed original research article in a scientific journal
Oral treatment with a vitamin D3 analogue (BXL628) has anti-inflammatory effects in rodent model of interstitial cystitis
Authors: Benigni F, Baroni E, Zecevic M, Zvara P, Streng T, Hedlund P, Colli E, D'Ambrosio D, Andersson KE
Publisher: BLACKWELL PUBLISHING
Publication year: 2006
Journal:BJU International
Journal name in sourceBJU INTERNATIONAL
Journal acronym: BJU INT
Volume: 97
Issue: 3
First page : 617
Last page: 624
Number of pages: 8
ISSN: 1464-4096
DOI: https://doi.org/10.1111/j.1464-410X.2006.05971.x
Abstract
Vitamin D3 analogues may successfully be used as anti-inflammatory agents in allergen-mediated inflammatory reactions. Moreover, the modulatory effect shown on mast cell activation by the BXL628 analogue strongly supports its potential therapeutic use in a possibly mast cell-dependent disease such as human interstitial cystitis.
Vitamin D3 analogues may successfully be used as anti-inflammatory agents in allergen-mediated inflammatory reactions. Moreover, the modulatory effect shown on mast cell activation by the BXL628 analogue strongly supports its potential therapeutic use in a possibly mast cell-dependent disease such as human interstitial cystitis.